WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $31.7 million in its fiscal third quarter.

On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of $1.53.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.36 per share.

The biotechnology company posted revenue of $19.5 million in the period, also falling short of Street forecasts. Five analysts surveyed by Zacks expected $20.3 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News